|
2N2F
Solution NMR structure of Dynorphin 1-13 bound to Kappa Opioid Receptor
Deposited 2015-05-06
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
207–219(13 aa)
Fragment:residues 207-219
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.1;280 K;Pressure ambient
NMR sample composition
1 mM [U-15N-GFLI] Dynorphin 1, 150 mM potassium chloride, 40 mM [U-2H] MES, 100 uM DSS, 10 uM KOR, 8 mM DDM, 1.6 mM CHS, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1 mM [U-15N-GFLIR; U-13C-R] Dynorphin 1, 150 mM potassium chloride, 40 mM [U-2H] MES, 100 uM DSS, 10 uM KOR, 8 mM DDM, 1.6 mM CHS, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
8F7W
Gi bound kappa-opioid receptor in complex with dynorphin
Deposited 2022-11-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain P
207–214(8 aa)
Fragment:UNP residues 207-214
|
Not recorded
|
CLR CHOLESTEROL × 3
PLM PALMITIC ACID × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.19 Å
|
|
8VJU
Structure of Human Neurolysin in complex with dynorphin A13 peptide
Deposited 2024-01-08
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
207–219(13 aa)
|
Not recorded
|
ZN ZINC ION × 2
EDO 1,2-ETHANEDIOL × 8
CL CHLORIDE ION × 1
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;17.5 ~ 30 % polyethylene glycol 3,350 and 50 ~ 125 mM Bis-Tris HCl buffer, pH 6.5
|
Resolution 1.99 Å
R-free 0.218
|
|
8VJV
Structure of Human Neurolysin in complex with dynorphin A8(1-8) peptide
Deposited 2024-01-08
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
207–214(8 aa)
|
Not recorded
|
ZN ZINC ION × 1
EDO 1,2-ETHANEDIOL × 3
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;17.5 ~ 30 % polyethylene glycol 3,350 and 50 ~ 125 mM Bis-Tris HCl buffer, pH 6.5
|
Resolution 2.12 Å
R-free 0.249
|
|
9CCF
Crystal Structure of DA7-2
Deposited 2024-06-21
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
207–223(17 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.6;293 K;0.1 M Sodium acetate pH 4.6 and 25% (v/v) PEG 550 MME
|
Resolution 4.00 Å
R-free 0.296
|
|
9CCF
Crystal Structure of DA7-2
Deposited 2024-06-21
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
207–223(17 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.6;293 K;0.1 M Sodium acetate pH 4.6 and 25% (v/v) PEG 550 MME
|
Resolution 4.00 Å
R-free 0.296
|
|
9L60
Gi-bound kappa opioid receptor in complex with dynorphin and positive allosteric modulator MPAM-15
Deposited 2024-12-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain P
207–219(13 aa)
|
Not recorded
|
CLR CHOLESTEROL × 2
A1D6C 9-[5-(3-chlorophenyl)furan-2-yl]-3,3,6,6-tetramethyl-4,5,7,9-tetrahydro-2~{H}-xanthene-1,8-dione × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.3
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|